Covaxin: India approves two Covid vaccines for children under 12:
Both Covaxin and Corbevax are already being administered to children above 12 years.
bbc.com/news/world-asia-india-55748124
Photo: bbc.com · view article
India Approves Covid Vaccines for Young ChildrenTwo domestic vaccines gained emergency use for ages 6-12 as India surpasses 1.87 billion doses administered nationwide.
- Covaxin and Corbevax have received emergency authorization for Covid vaccination in children aged six to twelve.
- Vaccination for this age group will commence only after approval from the National Technical Advisory Group.
- Since January 2021, India has delivered nearly 1.87 billion doses and fully vaccinated about 80% of eligible adults.
- Multiple vaccines including Covishield and Sputnik V are in active use, with other candidates undergoing trials.
be vetted independently— Dr Jeremy Kamil, a virologist at Louisiana State University Health Sciences Center in Shreveport, told the BBC that it was imperative that the efficacy data of the vaccine be vetted independently.
Story Details
| Last Updated | |
| Total Articles | 3 |
Main Topics
Indian biotechnological company, vaccine manufacturer
News on this topic
Covaxin: India approves two Covid vaccines for children under 12: Both Covaxin and Corbevax are already being administered to children above 12 years.
bbc.com/news/world-asia-india-55748124
2 new #COVIDvaccines , Covid pill approved for use
Both the doses – Covovax and Corbevax – approved are being produced in India ...
https://bit.ly/3FJfmSo
India Issues Emergency Use Authorisation For COVID-19 Vaccine Covovax | Full Details
india.com/news/india/india-emergency-use-authorisation-covid-19-vaccine-covovax-dgci-5160540/
Similar to This
Previous
FDA claims Covid shots killed 10 children and vows new vaccine rules: The director of the Food and Drug Administration’s vaccine division told agency staff in a ...
nbcnews.com/health/health-news/fda-covid-vaccines-children-deaths-rcna246437
Changing the FDA's Vaccine Approval Process Could Threaten COVID, Flu Protection for Children
scientificamerican.com/article/changing-the-fdas-vaccine-approval-process-could-threaten-covid-flu/
FDA official plans to change vaccine approval process, claiming that Covid-19 shots caused child deaths
cnn.com/2025/11/29/politics/vaccine-approval-process-fda-official
Banning mRNA COVID vaccine is ‘the goal,’ Florida surgeon general says: Joseph Ladapo was asked a question about the state’s recent announcement on vaccines.
tampabay.com/news/florida-politics/2025/09/15/ladapo-vaccines-desantis-covid-mrna-podcast-cdc/
Paid articlePaywall
RFK Jr. is not healthy for children and other living Americans: Santa Cruz physician Jeoffry B. Gordon warns that RFK Jr.’s new vaccine restrictions threaten ...
lookout.co/rfk-jr-is-not-healthy-for-children-and-other-living-americans/story
Getting a COVID vaccine just got more complicated after new FDA restrictions: The FDA narrowed approval of the new COVID-19 vaccines.
abcnews.go.com/Health/covid-vaccine-complicated-after-new-fda-restrictions/story
Key FactsLimited Access to Updated COVID-19 Vaccines Approved
Aug 28, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: apnews.com
Summary created with AI assistance · Source: apnews.com
- The FDA approved updated COVID-19 vaccines from Pfizer, Moderna, and Novavax for seniors and individuals with high-risk conditions.
- Pfizer’s vaccine lost emergency authorization for children under five, leaving Moderna as the only approved option for that age group.
- These vaccines target recent coronavirus variants and are expected to be distributed within weeks.
- Access barriers may arise due to insurance coverage rules and requirements to prove eligibility for vaccination.
The American people demanded science, safety, and common sense. This framework delivers all three.— Robert F. Kennedy Jr. expressed on social media regarding the new COVID-19 vaccines.
Who Is Eligible for the COVID Vaccine in 2025, and How to Get It: Many questions still surround COVID vaccine access this fall, but here’s what we know so far
scientificamerican.com/article/who-is-eligible-for-the-covid-vaccine-in-2025-and-how-to-get-it/
RFK Jr. Celebrates as FDA Ends COVID Vaccine Mandate: The announcement follows an exclusive Daily Beast report revealing Kennedy is eyeing a total ban on the ...
thedailybeast.com/rfk-jr-celebrates-as-fda-ends-covid-vaccine-mandate/
Moderna’s latest COVID-19 vaccine is both approved and ‘made in Canada’: An update to Moderna's COVID-19 vaccine that targets the newest variants and is made ...
globalnews.ca/news/11349082/new-covid-19-vaccine-made-in-canada/
Conflicting COVID-19 vaccine advice presents confusion for Michigan parents. What to know
detroitnews.com/story/news/local/michigan/2025/08/28/michigan-officials-doctors-promote-covid-vaccines-amid-conflicting-advice-confusion/85823093007/
FDA approves updated COVID-19 shots but limits access for some kids and adults: Their use was narrowed for younger adults and children to those with at least one ...
stltoday.com/life-entertainment/nation-world/wellness/article_5f3ad527-36ab-5c46-a2b5-8117414b8402.html
Vaccine situation will be complicated this year, experts warn: Those with private health insurance expected to have an easier time getting vaccines than those on ...
mercurynews.com/2025/08/25/vaccine-situation-will-be-complicated-this-year-experts-warn/
As RFK Jr. pushes to limit vaccines, MMR pioneer defends their lifesaving power: For decades, one of the world's most contagious diseases was considered ...
ocregister.com/2025/07/07/stanley-plotkin-mmr-pioneer-vaccines/
Experts warn RFK Jr. is unraveling the system that kept vaccines safe: Kennedy has long held many vaccine-skeptic views.
abcnews.go.com/Health/experts-warn-rfk-jr-unraveling-system-vaccines-safe/story
CDC's vaccine panel to take up longtime target of anti-vaccine groups: Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers meet next week ...
nbcnews.com/health/health-news/cdcs-vaccine-panel-take-longtime-target-anti-vaccine-groups-rcna213933
As COVID-19 cases register an uptick in India, a look at the vaccine stock position
thehindu.com/sci-tech/health/as-covid-19-cases-register-an-uptick-in-india-a-look-at-the-vaccine-stock-position/article69656143.ece
How to Think About COVID-19 Vaccines in the Era of R.F.K., Jr.: Dhruv Khullar on the Health and Human Services’ decision to stop recommending the vaccine for ...
newyorker.com/news/the-lede/how-to-think-about-covid-19-vaccines-in-the-era-of-rfk-jr
What New Zealand could gain from India’s booming pharmaceutical sector: As New Zealand eyes a free trade agreement with India, experts say the next frontier ...
rnz.co.nz/news/indonz/562129/what-new-zealand-could-gain-from-india-s-booming-pharmaceutical-sector
Moderna’s Super-Vaccine for Flu and Covid Works—Now Politics Could Sink It: A new trial suggests a combination vaccine may offer equal or better protection ...
gizmodo.com/modernas-super-vaccine-for-flu-and-covid-works-now-politics-could-sink-it-2000599293
Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study
thehindu.com/news/national/covaxin-shows-50-effectiveness-against-symptomatic-covid-19-in-real-world-assessment-says-lancet-study/article37657046.ece
Paid articlePaywallKey FactsCovaxin Provides 50% Protection Against Symptomatic COVID-19
Nov 24, 2021 · Reading time: ~30 sec.
Summary created with AI assistance · Source: thehindu.com
Summary created with AI assistance · Source: thehindu.com
- Two doses of the inactivated vaccine Covaxin offer 50 percent effectiveness against symptomatic COVID-19 among healthcare employees.
- The research took place amid India’s second COVID-19 surge, with the Delta variant responsible for approximately 80 percent of infections.
- Vaccine effectiveness remained stable for seven weeks following the second dose.
- The study focused on symptomatic infections and did not assess protection against severe disease or hospitalization.
Next